# Effect of Topical Insulin on Healing Rate of Pemphigus Lesions

> **NCT07461103** · PHASE2 · COMPLETED · sponsor: **Alexandria University** · enrollment: 20 (actual)

## Conditions studied

- Pemphigus Vulgaris
- Skin Erosion
- Autoimmune Blistering Disease

## Interventions

- **DRUG:** insulin glargine
- **DRUG:** human insulin
- **DRUG:** 0.9% Normal Saline

## Key facts

- **NCT ID:** NCT07461103
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-22
- **Primary completion:** 2025-08-10
- **Final completion:** 2025-08-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07461103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07461103, "Effect of Topical Insulin on Healing Rate of Pemphigus Lesions". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07461103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*